R.R. Donnelley & Sons Co. (RRD) Tops Q1 EPS by 4c; Boosts FY14 Sales Outlook
Get Alerts RRD Hot Sheet
Price: $10.84 --0%
Financial Fact:
Less: Income (loss) attributable to noncontrolling interests: 300K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Less: Income (loss) attributable to noncontrolling interests: 300K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
R.R. Donnelley & Sons Co. (NASDAQ: RRD) reported Q1 EPS of $0.31, $0.04 better than the analyst estimate of $0.27. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.71 billion.
R.R. Donnelley & Sons Co. sees FY2014 revenue of $11.5-11.8 billion, versus prior guidance of $11.5-11.7 billion and the consensus of $11.74 billion.
For earnings history and earnings-related data on R.R. Donnelley & Sons Co. (RRD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share